FDA won't require lengthy clinical trials for COVID-19 boosters - Yahoo

Retrieved on: 2022-07-01 17:58:58

Tags for this article:

Clinical trials

COVID-19 vaccination in the United States

RNA vaccines

Health

Medical research

COVID-19 pandemic in Botswana

SARS-CoV-2 Omicron variant

Pfizer-BioNTech COVID-19 vaccine

Moderna COVID-19 vaccine

Variants of SARS-CoV-2

COVID-19 vaccine

BioNTech

United States

u.s. food and drug administration

Click the tags to see associated articles and topics

FDA won't require lengthy clinical trials for COVID-19 boosters - Yahoo. View article details on HISWAI: https://www.yahoo.com/entertainment/fda-wont-require-lengthy-clinical-173134923.html

Excerpt

Boosters targeting BA.1 are still effective against BA.4 and BA.5, early data from Moderna and Pfizer/BioNTech suggests. But the immune response ...

Article found on: www.yahoo.com

View Original Article